Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
BIO
BIO
NYSE
Health Technology
Medical Specialties
305.96
USD
+4.26
+1.41%
Closed: 07-22 20:00 (UTC+0)
307.30
USD
+1.34
+0.44%
After Hours: 07-23 00:00 (UTC+0)

BIO Key Statistics

High
307.10
Open
301.00
Volume
275.06K
Low
298.74
Prev. Close
301.70
Trading Value
84.03M
52-Week High
343.12
Relative Volume
0.897
Amplitude (%)
2.77%
52-Week Low
236.73
Turnover Rate
1.27%
Market Cap
8.07B
P/E Ratio (TTM)
50.37
P/E Ratio (Annual)
10.978
P/B Ratio
1.2
P/S Ratio
3.16
Earnings Per Share (EPS)
6.075
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
21.70M
Currency Unit
USD

BIO Price Performance

7 day
30 day
90 day
180 day
Year to date
1 Year
BIO Money Flow Distribution
BIO Daily Short Sale Volume
BIO Short Interest History
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.07B, with a P/E ratio of 50.37. On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO near the upper end of its most recent trading range. Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is roughly in line with its usual level than usual. Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
Company Name
Bio-Rad Laboratories, Inc.
Sector
Health Technology
Industry
Medical Specialties
Exchanges
NYSE
Number of Employees
7,450
Lot Size
40
Official Website
Currency Unit
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

BIO FAQ